Ironwood Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
IRWD
CUSIP
46333X108
Type
Equity
Class
COM CL A
Num filings
159
Total reported value, excl. options
$106 M
Manager Report Date Value ($000) Shares Option Type